InspireMD, Inc.
PosiFunda Ratios Only on PositoAI
PositoAI's own ratios from InspireMD, Inc.'s yearly results (2022–2025), compared with Healthcare companies in United States. Tap ? on any ratio for what it means.
What stands out
- Cash Cushion Ratio: Cash, after subtracting all debt, is 2.4 times its market value (net cash). Higher than 96% of Healthcare companies in United States.
- Growth Efficiency Ratio: Sales grew 74% in 3 years, but profit fell: $796 less profit per $100 of extra sales. Lower than 95% of Healthcare companies in United States.
- Cash Locked Ratio: For every $100 of sales, $49 is tied up in day-to-day operations (money owed by customers + stock − money owed to suppliers), against $40 tied up three years earlier. More money tied up than 92% of Healthcare companies in United States.
Cash quality
Profit Cash Ratio
—Loss-making or profit too small
Over the last 3 years profit was a loss or under 2% of sales, so cash per 100 of profit is not meaningful.
Self-Funding Ratio
-21.3×Over the last 3 years operating cash was negative while the company kept spending on investment (capex).
Lower than 58% of Healthcare companies in United States.
Cash Locked Ratio
$49For every $100 of sales, $49 is tied up in day-to-day operations (money owed by customers + stock − money owed to suppliers), against $40 tied up three years earlier.
More money tied up than 92% of Healthcare companies in United States.
Growth quality
Steadiness Ratio
3/3 · 0/3Sales grew in 3 of the last 3 years; profit grew in 0 of 3.
Steadier than 50% of Healthcare companies in United States.
Growth Efficiency Ratio
−$796Sales grew 74% in 3 years, but profit fell: $796 less profit per $100 of extra sales.
Lower than 95% of Healthcare companies in United States.
Asset Productivity Ratio
+74% / +182%In 3 years sales changed by +74% while total assets changed by +182%. Assets grew faster than sales.
Balance-sheet strength
Debt Due Cover Ratio
-32.9×Operating cash was negative last year, while some debt falls due within a year.
Lower than 65% of Healthcare companies in United States.
Cash Cushion Ratio
2.4× cashCash, after subtracting all debt, is 2.4 times its market value (net cash).
Higher than 96% of Healthcare companies in United States.
Tangible Assets Ratio
—Data incomplete
Tangible Net Worth Ratio
—Data incomplete
Shareholders
Standard fundamentals
P/E, P/B, ROE, debt, growth and more (12)
InspireMD, Inc. made a loss over the last year. InspireMD, Inc. owes $0.29 for every $1 it owns. InspireMD, Inc. made a loss in each of the last two years.
Compared with Healthcare companies in United States · latest annual results Dec 2025.
P/E ratio
LossInspireMD, Inc. made a loss over the last year, so its P/E ratio is not meaningful.
P/B ratio
0.67The share price is 0.67 times InspireMD, Inc.'s book value per share, lower than 87% of Healthcare companies in United States.
Market cap
$21 MThe total market value of all of InspireMD, Inc.'s shares at today's price (share price × number of shares), smaller than 82% of Healthcare companies in United States. PosiCap size class: Micro Cap.
Net worth (book value)
$32 MWhat InspireMD, Inc. would have left on paper if it sold everything it owns and paid everything it owes, from its latest balance sheet (30 Jun 2026).
Book value per share
$0.68Net worth divided by the number of shares. The share price of $0.45 is 0.7 times this, which is the P/B above.
Return on equity (ROE)
-202.8%InspireMD, Inc. lost 202.8% of its shareholders' money over the last year, lower than 84% of Healthcare companies in United States.
Owes vs Owns
0.29×InspireMD, Inc. owes $0.29 for every $1 it owns (low), lower than 60% of Healthcare companies in United States.
Dividend yield
NoneInspireMD, Inc. does not currently pay a dividend.
Revenue growth
+28%Revenue rose 28% in the year to Dec 2025, and grew 20% a year on average over 3 years.
Profit growth
LossInspireMD, Inc. made a loss in each of the last two years.
Profit margin
-543.3%InspireMD, Inc. lost $543 for every $100 of revenue.
Cash vs debt
Net cashInspireMD, Inc. held $51 M more cash than debt (net cash) at Dec 2025.
Questions
How is P/B calculated on PositoAI?
P/B is market cap divided by net worth from the latest balance sheet. For InspireMD, Inc.: $21 M ÷ $32 M (30 Jun 2026) = 0.7.
What is InspireMD, Inc.'s return on equity?
InspireMD, Inc. lost 202.8% of its shareholders' money over the last year, lower than 84% of Healthcare companies in United States.
How much does InspireMD, Inc. owe compared with what it owns?
InspireMD, Inc. owes $0.29 for every $1 it owns (low), lower than 60% of Healthcare companies in United States.
Does InspireMD, Inc. pay a dividend?
No. InspireMD, Inc. does not currently pay a dividend.
Is InspireMD, Inc.'s revenue growing?
Revenue rose 28% in the year to Dec 2025, and grew 20% a year on average over 3 years.
Figures from the company's yearly results and PositoAI's own data. Full tables are on the Go Deep tab. What each figure means. PositoAI is for research and education only and is not investment advice.